Govt to review decision after demand assessment.
It was in 2005, India changed its patent law and started granting patents in medicines.
Subscriber churn costs operators heavily, retailers make Rs 7.7k cr a year.
The prices of essential medicines may drop, as the National Pharmaceutical Pricing Authority (NPPA) has made significant changes in its norms to rationalise price approvals.
Idea tops list of companies with high percentage of active subscribers.
For mobile customers who thought the high price of 4G devices would keep them away from high-speed internet, here is the game changer.
Orders surprise inspections at chemists and pharma stores.
The broadcaster had bought the stake in 2004.
CCI, sector regulators may consult each other if jurisdictions overlap
Moolchand Healthcare Pvt Ltd, the corporate entity formed by the group in 2006 with expansion in mind, is on an acquisition spree for hospital chains, IVF (in vitro fertilisation) clinics and pathological laboratories.
Government makes observation in reply to attorney general's question for Presidential reference
Toughens stand days before cooling-off period ends
This helps consumers check the authenticity of drugs simply by sending SMSes.
Financial pressure on the parent company triggered the move.
Import alert on unit-6 facility might be lifted by FDA by Sept.
Reebok's staff to get voluntary retirement option, stores may be reduced by a third.
Drug maker Cipla Ltd is rejigging its China business. The pharma company recently exited a significant part of its investment in its Chinese partner Desano Holdings, while ploughing back a part of the funds into the group's units manufacturing biosimilars and active pharmaceutical ingredients (APIs).
Companies such as Dr Reddy's Laboratories, Sun Pharmaceutical, Lupin and Ranbaxy striving to capitalise on opportunities created by pro-generic health care reforms in the US market are facing pricing pressure as the health care supply chain is undergoing consolidation.
Videocon starts race, says will bid in eight circles, expects 5-MHz spectrum to go for Rs 20,000 crore
A presentation by the CBI to a Joint Parliamentary Committee last week said the decision led to a loss of Rs 508 crore to the exchequer.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances